O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.83%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.4B
AUM Growth
+$10.4B
(+9.5%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
34.73%
Holding
147
New
10
Increased
27
Reduced
30
Closed
6
Top Buys
| 1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$176M |
| 2 |
AET
Aetna Inc
AET
|
$80.9M |
| 3 |
Universal Health Services
UHS
|
$74.2M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$70.8M |
| 5 |
KALA BIO
KALA
|
$54.3M |
Top Sells
| 1 |
Humana
HUM
|
$185M |
| 2 |
Insmed
INSM
|
$78.6M |
| 3 |
Edwards Lifesciences
EW
|
$49M |
| 4 |
HCA Healthcare
HCA
|
$32.6M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$31.7M |
Sector Composition
| 1 | Healthcare | 91.68% |
| 2 | Financials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $511M | 4.89% | 3,645,486 -226,300 | -6% | -$31.7M |
|
2
Biogen
BIIB
$19.4B
| $510M | 4.88% | 1,630,000 | – | – |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $489M | 4.67% | 3,351,977 -73,800 | -2% | -$10.8M |
|
4
Boston Scientific
BSX
$156B
| $391M | 3.73% | 13,397,000 -1,003,000 | -7% | -$29.3M |
|
5
Merck
MRK
$210B
| $351M | 3.36% | 5,487,000 | – | – |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $315M | 3.01% | 2,074,302 +47,800 | +2% | +$7.27M |
|
7
Puma Biotechnology
PBYI
$254M
| $290M | 2.78% | 2,425,735 | – | – |
|
8
Eli Lilly
LLY
$657B
| $263M | 2.51% | 3,075,000 | – | – |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $256M | 2.45% | 572,770 +106,000 | +23% | +$47.4M |
|
10
Cigna
CI
$80.3B
| $237M | 2.26% | 1,266,100 +44,000 | +4% | +$8.23M |
|
11
Amgen
AMGN
$155B
| $234M | 2.23% | 1,253,100 -49,600 | -4% | -$9.25M |
|
12
Agilent Technologies
A
$35.7B
| $234M | 2.23% | 3,638,900 -175,200 | -5% | -$11.2M |
|
|
WMGI
13
DELISTED
Wright Medical Group Inc
WMGI
| $231M | 2.21% | 8,946,234 | – | – |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $222M | 2.12% | 1,396,500 +508,600 | +57% | +$80.9M |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $197M | 1.88% | 2,388,670 +284,300 | +14% | +$23.4M |
|
16
Elevance Health
ELV
$71.8B
| $176M | 1.68% | 927,618 +7,000 | +0.8% | +$1.33M |
|
|
CMTA
17
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $176M | 1.68% | +10,425,225 | New | +$176M |
|
18
AbbVie
ABBV
$372B
| $175M | 1.67% | 1,965,000 -232,600 | -11% | -$20.7M |
|
|
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
| $174M | 1.67% | 14,182,900 | – | – |
|
20
Incyte
INCY
$16.5B
| $172M | 1.65% | 1,476,000 -187,400 | -11% | -$21.9M |
|
|
LOXO
21
DELISTED
Loxo Oncology, Inc
LOXO
| $159M | 1.52% | 1,728,000 | – | – |
|
22
Gilead Sciences
GILD
$140B
| $156M | 1.49% | 1,928,000 -145,400 | -7% | -$11.8M |
|
|
23
Edwards Lifesciences
EW
$47.8B
| $152M | 1.45% | 1,390,700 -448,600 | -24% | -$49M |
|
24
Johnson & Johnson
JNJ
$427B
| $146M | 1.4% | 1,124,400 | – | – |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $140M | 1.34% | 9,996,816 +5,067,858 | +103% | +$70.8M |
|